Cargando…
Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study
PURPOSE: Licaminlimab is a new anti-TNFα antibody fragment for topical ocular application. This phase II study assessed the tolerability, treatment effect, and pharmacokinetics of licaminlimab in acute anterior uveitis (AAU). METHODS: In this multicenter, randomized, parallel-group, double-masked st...
Autores principales: | Pasquali, Theodore A., Toyos, Melissa M., Abrams, David B., Scales, David K., Seaman, John W., Weissgerber, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206391/ https://www.ncbi.nlm.nih.gov/pubmed/35704329 http://dx.doi.org/10.1167/tvst.11.6.14 |
Ejemplares similares
-
Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study
por: Shettle, Lee, et al.
Publicado: (2022) -
TNF receptor-associated factor 5 gene confers genetic predisposition to acute anterior uveitis and pediatric uveitis
por: Xiang, Qin, et al.
Publicado: (2013) -
Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis
por: Goldstein, Debra A., et al.
Publicado: (2016) -
Cytomegalovirus anterior uveitis in immunocompetent individuals following topical prostaglandin analogues
por: Babu, Kalpana, et al.
Publicado: (2013) -
Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery
por: Guell, Jose, et al.
Publicado: (2019)